Literature DB >> 10692496

RPR112378 and RPR115781: two representatives of a new family of microtubule assembly inhibitors.

C Combeau1, J Provost, F Lancelin, Y Tournoux, F Prod'homme, F Herman, F Lavelle, J Leboul, M Vuilhorgne.   

Abstract

A screening program aimed at the discovery of new antimicrotubule agents yielded RPR112378 and RPR115781, two natural compounds extracted from the Indian plant Ottelia alismoides. We report their isolation, structural determination, and mechanisms of action. RPR112378 is an efficient inhibitor of tubulin polymerization (IC(50) = 1.2 microM) and is able to disassemble preformed microtubules. Regarding tubulin activity, RPR115781 is 5-fold less active than RPR112378. Tubulin-RPR112378 complexes, when isolated by gel filtration, were able to block further tubulin addition to growing microtubules, a mechanism that accounts for the substoichiometric effect of the drug. RPR112378 was found to prevent colchicine binding but not vinblastine binding to tubulin. Although colchicine binding is known to induce an increase of tubulin GTPase activity, no such increase was observed with RPR112378. We show that RPR112378 is a highly cytotoxic compound and that RPR115781 is 10, 000-fold less active as an inhibitor of KB cell growth. Part of the cytotoxicity of RPR112378 is probably caused by a reaction of addition with sulfhydryl groups, an observation that has not been made with RPR115781. In conclusion, these molecules represent a new class of inhibitors of microtubule assembly with potential therapeutic value.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10692496     DOI: 10.1124/mol.57.3.553

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  6 in total

1.  Novel combretastatin A-4 derivative XN0502 induces cell cycle arrest and apoptosis in A549 cells.

Authors:  Hong Zhu; Jun Zhang; Na Xue; Yongzhou Hu; Bo Yang; Qiaojun He
Journal:  Invest New Drugs       Date:  2010-03-30       Impact factor: 3.850

Review 2.  An overview of tubulin inhibitors that interact with the colchicine binding site.

Authors:  Yan Lu; Jianjun Chen; Min Xiao; Wei Li; Duane D Miller
Journal:  Pharm Res       Date:  2012-07-20       Impact factor: 4.200

3.  Synthesis and antiproliferative activities of ottelione a analogues.

Authors:  Tsai-Yuan Chang; Yun-Peng Tu; Win-Yin Wei; Hsiang Yu Chen; Chih-Shang Chen; Ying-Shuan E Lee; Jiann-Jyh Huang; Chin-Kang Sha
Journal:  ACS Med Chem Lett       Date:  2012-10-30       Impact factor: 4.345

4.  Allocolchicinoids bearing a Michael acceptor fragment for possible irreversible binding of tubulin.

Authors:  Ekaterina S Sazanova; Iuliia A Gracheva; Diane Allegro; Pascale Barbier; Sébastien Combes; Elena V Svirshchevskaya; Alexey Yu Fedorov
Journal:  RSC Med Chem       Date:  2020-06-04

5.  New diarylheptanoids and a hydroxylated ottelione from Ottelia alismoides.

Authors:  Thomas R Hoye; Seif-Eldin N Ayyad; Hollie J Beckord; Susan G Brown
Journal:  Nat Prod Commun       Date:  2013-03       Impact factor: 0.986

6.  Curcumin binds tubulin, induces mitotic catastrophe, and impedes normal endothelial cell proliferation.

Authors:  Steven J T Jackson; Laura L Murphy; Richard C Venema; Keith W Singletary; Andrew J Young
Journal:  Food Chem Toxicol       Date:  2013-08-11       Impact factor: 6.023

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.